Porto-sinusoidal vascular disorder (PSVD) is a rare complication of this treatment, and its pathophysiology is not fully understood. A 43-year-old female patient was diagnosed with locally advanced HER2-overexpressing breast cancer, treated with primary chemotherapy, followed by surgery and adjuvant radiotherapy and trastuzumab. This evidence concerns the gene ERBB2 and breast carcinoma.